Jessica Ribkoff

CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real‐world practice

A. Kaempf, M. West, J. Shatzel, 2021, European journal of haematology.

The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients

T. Deloughery, H. Al‐Samkari, J. Shatzel, 2019, European journal of haematology.

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer

A. Kaempf, M. West, Thomas Kartika, 2023, The oncologist.

Incidence of False-Positive Direct Anti Globulin Tests (DAT): A Single-Center Retrospective Analysis.

T. Deloughery, Jessica Ribkoff, S. Olson, 2020 .

Real-world analysis of disease progression after CDK 4/6 inhibitor (CDKi) therapy in patients with hormone receptor positive (HR+)/HER2- metastatic breast cancer (MBC).

A. Kaempf, M. West, Thomas Kartika, 2021, Journal of Clinical Oncology.